Bio-Path Holdings to Present at the Biotech Showcase 2015 Conference in San Francisco, CA on Tuesday, January 13, 2015 at 3:30 p.m. Pacific Time BiotechShowcaseAlert01132015
Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma – Company Broadening its Pipeline with Second Product Candidate – Bio_Path_Initiates_Devel_Liposomal_Bcl_2
NASDAQ Release: Bio-Path Holdings, Inc. to Ring The NASDAQ Stock Market Closing Bell (Friday, October 17, 2014 at 3:45 – 4:00 PM Eastern Time) Nasdaq_bell_release_10_14
Bio-Path Holdings Successfully Completes Cohort 6 of Phase I Clinical Trial Evaluating Liposomal Grb-2 in Blood Cancers PR_Cohort_6_complete
Bio-Path Holdings to Present at the 13th Annual BIO Investor Forum in San Francisco on Tuesday October 7, 2014 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) BioPath_Holdings_to_present_at_13th_Bio_Investor_Forum
Bio-Path Holdings Added to Russell Global, Russell 3000 and Russell Microcap Indexes RussellIndex_20140630
